Shan Ahmed Khan

Shan Ahmed Khan is a senior markets reporter at TS2.tech, specializing in stocks, technology and macroeconomic trends. A graduate of the Lahore University of Management Sciences (LUMS), he previously worked in investment research and market analysis. His coverage helps readers understand the key developments influencing global financial markets and emerging industries.

Vanda (VNDA) stock jumps 28% after FDA approves Nereus motion-sickness drug

Vanda (VNDA) stock jumps 28% after FDA approves Nereus motion-sickness drug

Vanda Pharmaceuticals shares jumped 28.1% to $9.01 at 1:38 p.m. ET on Wednesday after the company said the U.S. Food and Drug Administration approved Nereus to prevent vomiting induced by motion. Vanda said the oral drug is a neurokinin-1 receptor antagonist — meaning it blocks a receptor involved in nausea signaling — and called it the first new pharmacologic motion-sickness treatment in more than four decades. In late-stage Phase 3 trials — the final stage before approval — vomiting rates were about 10%–20% on Nereus versus 38%–44% on placebo, and Vanda said it expects to launch the drug in coming months. PR Newswire
31 December 2025
New Year 2026 messages flood Romanian media as DefenseRomania touts nearly 6 million readers

New Year 2026 messages flood Romanian media as DefenseRomania touts nearly 6 million readers

Defense-focused outlet DefenseRomania marked the end of 2025 with a New Year message to readers, saying it closed the year with nearly 6 million unique visitors and promising more exclusive reporting in 2026. https://www.defenseromania.ro/defenseromania-va-ureaza-la-multi-ani-si-un-2026-cu-tot-ce-va-doriti-va-multumim-ca-ne-ati-fost-alaturi-intr-un-numar-atat-de-mare-in-2025-si-promitem-sa-nu-ne-oprim-aici_639622.html
31 December 2025
Artisan Value Fund reveals why it dumped Cigna for Elevance — and why ASML stays a top bet

Artisan Value Fund reveals why it dumped Cigna for Elevance — and why ASML stays a top bet

Artisan Partners’ Artisan Value Fund said in its third-quarter 2025 investor letter that it sold The Cigna Group and bought Elevance Health, citing rising policy risk around pharmacy benefit managers. The fund also reiterated conviction in ASML Holding, keeping the chip-equipment maker among its top positions. Insider Monkey
Why Rush Street Interactive (RSI) stock is down today: Zacks downgrade to “hold”

Why Rush Street Interactive (RSI) stock is down today: Zacks downgrade to “hold”

Rush Street Interactive, Inc. shares were down 3.6% on Wednesday after Zacks Research downgraded the online-gambling operator to “hold,” MarketBeat reported. The stock was down 72.5 cents at $19.39 by 12:46 p.m. ET after trading between $19.36 and $20.27, on about 318,000 shares. MarketBeat said the stock still carries a “Moderate Buy” consensus rating and an average target price of $21.25, and pegged its market value at about $4.6 billion. MarketBeat
31 December 2025
1 356 357 358 359 360 609
AI PORTFOLIO

Top Stock Picks

Today’s highest-ranked model selections.

#1 STRONG BUY

Xylem

NYSE: XYL 95 / 100
#2 BUY

AerCap

NYSE: AER 93 / 100
#3 BUY ON WEAKNESS

Visa

NYSE: V 90 / 100
#4 TACTICAL BUY

Chevron

NYSE: CVX 87 / 100
#5 ACCUMULATE

UPS

NYSE: UPS 84 / 100
View full portfolio
Editorial model selection. Not personalised advice.